SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001753926-21-000730
Filing Date
2021-11-23
Accepted
2021-11-23 07:17:44
Documents
15
Period of Report
2021-11-22

Document Format Files

Seq Description Document Type Size
1 6-K g082455_6k.htm 6-K 11460
2 EXHIBIT 99.1 g082455_ex99-1.htm EX-99.1 15108
3 EXHIBIT 99.2 g082455_ex99-2.htm EX-99.2 470219
4 EXHIBIT 99.3 g082455_ex99-3.htm EX-99.3 42431
5 EXHIBIT 99.4 g082455_ex99-4.htm EX-99.4 15075
6 EXHIBIT 99.5 g082455_ex99-5.htm EX-99.5 7051
7 GRAPHIC ex991001.jpg GRAPHIC 14056
8 GRAPHIC ex992001.jpg GRAPHIC 8060
9 GRAPHIC ex993001.jpg GRAPHIC 7047
10 GRAPHIC ex993002.jpg GRAPHIC 3971
11 GRAPHIC ex993003.jpg GRAPHIC 339
12 GRAPHIC ex994001.jpg GRAPHIC 3971
13 GRAPHIC ex994002.jpg GRAPHIC 339
14 GRAPHIC ex994003.jpg GRAPHIC 3055
15 GRAPHIC img001_v3.jpg GRAPHIC 3884
  Complete submission text file 0001753926-21-000730.txt   625111
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40858 | Film No.: 211434666
SIC: 2834 Pharmaceutical Preparations